Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

More Press Releases

Stocks, bond yields fall sharply as growth worries spread

Mar 23, 2019

Wall Street was roiled Friday by new signs that global economic growth is slowing. The jitters triggered a sell-off in stocks and sent bond yields sharply lower, flashing a possible recession warning. The wave of selling knocked 460 points off the Dow Jones Industrial Average and gave the benchmark S&P 500 index its worst day since Jan. 3. The Russell 2000 index of smaller company stocks fell more than the rest of the market as traders offloaded risker assets. Worried investors shifted money into bonds, which sent yields much lower. The yield on the 10-year Treasury dropped to 2.43 percent...

Markets Right Now: Stocks, yields drop on growth worries

Mar 23, 2019

NEW YORK — The latest on developments in financial markets (all times local): 4 p.m. Stocks closed broadly lower on Wall Street, erasing their gains for the week, as investors became increasingly worried that the global economy is slowing down. Traders shifted money into bonds and other low-risk assets Friday. Bond yields fell sharply, hurting bank stocks and flashing a possible recession warning. Citigroup slumped 4.6 percent. Boeing fell 2.8 percent after Indonesia's flag carrier said it would seek to cancel an order of the company's planes. The S&P 500 fell 54 points, or 1.9 percent, to 2,800. The Dow...

Trump to nominate conservative Stephen Moore for Fed board

Mar 23, 2019

WASHINGTON — President Donald Trump said Friday that he will nominate Stephen Moore, a conservative economic analyst and frequent critic of the Federal Reserve, to fill a vacancy on the Fed's seven-member board. Moore, a well-known and often polarizing figure in Washington political circles, served as an adviser to Trump during the 2016 campaign. In that role, he helped draft Trump's tax cut plan. Trump has been harshly critical of the Fed's rate increases even after the central bank announced this week that it foresees no hikes this year. Moore, formerly chief economist for the conservative Heritage Foundation, has also...

Italy, China deepen ties under wary gaze of US, EU

Mar 23, 2019

MILAN — Italy's head of state told visiting Chinese President Xi Jinping on Friday that China's new "Silk Road" linking Europe and Asia must be a "two-way street," addressing concerns among Western allies that the colossal infrastructure project is meant merely to amplify Beijing's global influence. During Xi's two-day official state visit, Italy is expected to become the first major democracy to sign an agreement to join China's "Belt and Road" initiative. The program aims to invest in ports, roads, airports and railways in Asia, Africa and Europe to create a conduit for trade and China's construction industry. Both the...

Stocks fall on growth worries, Brexit doubts

Mar 23, 2019

SINGAPORE — Stocks fell sharply in Europe on Friday after surveys showed manufacturing in the region slowed in March and amid news that the European Union offered only a brief extension to the Brexit deadline. U.S. markets also appeared headed for a lower open. Britain's FTSE 100 led the decline, trading down 1.3 percent at 7,260, while the CAC 40 in France slid 1.2 percent to 5,315. Germany's DAX lost 0.7 percent to 11,467. The future contract for the Dow Jones Industrial Average was 0.7 percent lower at 25,828. That for the broad S&P 500 index also lost 0.7 percent,...

Subscribe to our newsletter!

Your Name

Your Email Address